July 2019
Volume 60, Issue 9
Free
ARVO Annual Meeting Abstract  |   July 2019
Clinical characteristics of proven acute intraocular toxicity by perfluorocarbon liquids (PFCL) used in retinal surgery
Author Affiliations & Notes
  • Jose-Carlos Pastor
    IOBA-Eye Institute, University of Valladolid, Arroyo, Valladolid, Spain
    Ophthalmology, Hospital Clinico Universitario, Valladolid, Valladolid, Spain
  • Cristina Andres_iglesias
    IOBA-Eye Institute, University of Valladolid, Arroyo, Valladolid, Spain
  • Girish Kumar Srivastava
    IOBA-Eye Institute, University of Valladolid, Arroyo, Valladolid, Spain
  • Ivan Fernandez-Bueno
    IOBA-Eye Institute, University of Valladolid, Arroyo, Valladolid, Spain
  • Antonio Dueñas-Laita
    IOBA-Eye Institute, University of Valladolid, Arroyo, Valladolid, Spain
    Medicine and Toxicology, University of Valladolid, Spain
  • Fernando Rull
    Crystallography and Mineralogy, University of Valladolid, Valladolid, Valladolid, Spain
  • Jesús Medina
    Crystallography and Mineralogy, University of Valladolid, Valladolid, Valladolid, Spain
  • Juan García-Serna
    High Pressure Processes Group, University of Valladolid, Valladolid, Valladolid, Spain
    Bioeconomy Institute, Department of Chemical Engineering and Environmental Technologies, University of Valladolid, Valladolid, Valladolid, Spain
  • Alfredo Garcia-Layana
    Ophthalmology, University of Navarra, Pamplona, Navarra, Spain
    Oftared, Instituto de Salud Carlos III, Madrid, Madrid, Spain
  • Rosa Coco-Martin
    IOBA-Eye Institute, University of Valladolid, Arroyo, Valladolid, Spain
  • Footnotes
    Commercial Relationships   Jose-Carlos Pastor, None; Cristina Andres_iglesias, None; Girish Srivastava, None; Ivan Fernandez-Bueno, None; Antonio Dueñas-Laita, None; Fernando Rull, None; Jesús Medina, None; Juan García-Serna, None; Alfredo Garcia-Layana, None; Rosa Coco-Martin, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 6597. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jose-Carlos Pastor, Cristina Andres_iglesias, Girish Kumar Srivastava, Ivan Fernandez-Bueno, Antonio Dueñas-Laita, Fernando Rull, Jesús Medina, Juan García-Serna, Alfredo Garcia-Layana, Rosa Coco-Martin; Clinical characteristics of proven acute intraocular toxicity by perfluorocarbon liquids (PFCL) used in retinal surgery. Invest. Ophthalmol. Vis. Sci. 2019;60(9):6597.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Adequate collaboration among ophthalmologists, scientific societies, and the Spanish Agency of Medicines and Medical Devices (AEMPS) have allowed the identification of proven cases of acute toxicity by some PFCL used in retinal surgery since 2013. Our aim is to define the clinical patterns of such toxicity so that retinal specialists from other countries can recognize potential cases and declare them to their National Health Agencies

Methods : Clinical cases of suspected acute toxicity declared to the AEMPS were reviewed (n: 129). Since 2015 (n=125), all cases were analyzed for potential cell cytotoxicity using a direct contact method developed by our group (Srivastava GK et al. Scientific Reports 2017;1425). Those producing >30% cell mortality were considered cytotoxic (ISO guidelines 16672 and 10993). Also chemical analysis were done by Fourier-transformed infrared (FTIR) spectroscopy and gas chromatography coupled to a single quadrupole mass spectrometer (GC-MS). Clinical information of the confirmed cases was evaluated and grouped by an expert committee of the Spanish Vitreo-Retina Society (SERV).

Results : 125 of the 129 suspected cases were fully confirmed to have used cytotoxic PFCL. The following toxic compounds were identified in different lots: ethyl benzene, dodecafluoroheptanol, perfluorooctanoic acid, P-xylene, O-xylene and bromotributyl stannane. Four major clinical patterns were defined: 1. Amaurosis or no light perception the day after the surgery is highly suspicious; 2. Optic nerve atrophy usually detected in less than 1 month after surgery not related to ocular hypertension; 3. Extensive areas of acute retinal necrosis; or 4. Retinal vascular occlusion(arterial or and/venous) w/w retinal hemorrhages.

Conclusions : For reasons not yet fully clarified, certain PFCL are producing profound visual loss right after their use in retinal surgery. Although changes have been proposed to modify ISO guidelines (16672, ophthalmic implants/ocular endotamponades), clinicians must be aware of this problem so that they can immediately report suspected cases to their respective National Health Agencies. Nevertheless manufacturing companies collaboration is required to avoid these problems in the future.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×